Recently, Diao et al. 22 identified ZEB2-AS1 as a putative oncogenic lncRNA and a novel prognostic biomarker in HNSCC, revealed that overexpression of ZEB2-AS1 associates with tumor aggressiveness and unfavorable prognosis. Here, ZEB2 is linked to neoplasm.